Previous 10 | Next 10 |
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting Findings Show Median Overall Survival Of 26 Months for Patients Receiving Ablative Doses with MRIdian MRI-Guided Radiation Therapy PR ...
Helsinki University Hospital Selects MRIdian® System for Installation at Comprehensive Cancer Center Center will be the first in Finland to offer MRIdian MR-guided radiation therapy cancer treatment PR Newswire CLEVELAND , Oct. 25, 2021 /PRNewswire/ --...
Baptist Health South Florida to Acquire a Second ViewRay MRIdian® MR-Guided Radiation Therapy System Eugene M. & Christine E. Lynn Cancer Institute to deliver on its continued commitment to excellence and innovation in cancer care, as one of only three locations in S. F...
Gainers: Camber Energy (NYSE:CEI) +27%. HCW Biologics (NASDAQ:HCWB) +21%. Fuel Tech (NASDAQ:FTEK) +23%. RedHill (NASDAQ:RDHL) +19%. Harmony (NASDAQ:HRMY) +15%. Ginkgo Bioworks (NYSE:DNA) +15%. Arqit Quantum (NASDAQ:ARQQ) +14%. AlloVir (NASDAQ:ALVR) +13%. ViewRay (NASDAQ:VRAY) +13%. Full Truck...
ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on October 28, 2021 PR Newswire CLEVELAND , Oct. 18, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company will host a Virtual Clinical Data Event for Investors ...
ViewRay Announces Conference Call for Third Quarter 2021 Financial Results to be Held After Market on November 4, 2021 PR Newswire CLEVELAND , Oct. 14, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its t...
Shares of ViewRay Inc. (NASDAQ:VRAY) traded today at $7.49, eclipsing its 52-week high. This new high was reached on below average trading volume as 202,000 shares traded hands, while the average 30-day volume is approximately 1.5 million shares. ViewRay Inc is a radiation therapy and im...
ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations New suite of workflow and clinical features to be highlighted at upcoming ASTRO 2021 conference PR Newswire CLEVELAND , Sept. 29, 2021 /PRNewswire/ -- ViewRay, Inc. (...
ViewRay Inc. (NASDAQ:VRAY) traded at a new 52-week high today of $7.48. This new high was reached on below average trading volume as 202,000 shares traded hands, while the average 30-day volume is approximately 1.5 million shares. Based on a current price of $7.42, ViewRay Inc. is curren...
ViewRay® to Partcipate in the Cantor Global Healthcare Conference PR Newswire CLEVELAND , Sept. 16, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the Cantor Global Healthcare Conference. Scott Drake ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...